Literature DB >> 6299124

Papillomavirus infection of the cervix. II. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins.

R J Kurman, A B Jenson, W D Lancaster.   

Abstract

Three hundred twenty-two cases of cervical dysplasia (mild, moderate, and severe) and carcinoma in situ (CIS) were examined for the presence of papillomavirus structural antigens with a peroxidase-antiperoxidase method on formalin-fixed, paraffin-embedded tissue. The primary antiserum, prepared from purified, detergent-disrupted bovine papillomavirus type 1 virions, is broadly reactive against the genus-specific (common) antigen(s) of the papillomaviruses. Using the peroxidase-antiperoxidase technique on cervical tissue obtained from biopsy, conization and hysterectomy specimens, papillomavirus structural proteins were identified in association with mild dysplasia in 65 of 152 (43%) cases, with moderate dysplasia in 12 of 82 (15%) cases, with severe dysplasia in eight of 47 (17%) cases, and with CIS in four of 41 (10%) cases. Papillomavirus antigens were found directly within the lesion in all the cases of mild and moderate dysplasia but in only two instances of severe dysplasia and in none of the examples of CIS. In the remaining 10 cases of severe dysplasia and CIS associated with the presence of papillomavirus antigens, cells containing papillomavirus structural proteins were present in areas of moderate dysplasia immediately adjacent to the high-grade lesions in seven instances and in areas of mild or moderate dysplasia not directly in contact with the high-grade lesions in three. Among the 12 high-grade lesions associated with the presence of papillomavirus antigens, a morphologic transition from areas of moderate dysplasia containing papillomavirus antigens to the areas of severe dysplasia and CIS was present in five instances. The results of this study, therefore, provide direct evidence demonstrating the relationship of papillomavirus to intraepithelial cervical neoplasia ranging from mild dysplasia to severe dysplasia and CIS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299124

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

Review 1.  Laboratory techniques in the investigation of human papillomavirus infection.

Authors:  E M de Villiers
Journal:  Genitourin Med       Date:  1992-02

Review 2.  The molecular biology of human papillomaviruses and the pathogenesis of genital papillomas and neoplasms.

Authors:  R S Ostrow; A J Faras
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Routine papillomavirus antigen staining of cervical punch biopsy specimens.

Authors:  D Jenkins; S K Tay; P H Maddox
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

4.  Social implications of sexually transmitted diseases.

Authors:  D Delva
Journal:  Can Fam Physician       Date:  1983-10       Impact factor: 3.275

5.  Detection of human papillomavirus infection in squamous tumours of the conjunctiva and lacrimal sac by immunohistochemistry, in situ hybridisation, and polymerase chain reaction.

Authors:  Y Nakamura; Y Mashima; K Kameyama; M Mukai; Y Oguchi
Journal:  Br J Ophthalmol       Date:  1997-04       Impact factor: 4.638

6.  Anal smear test to diagnose occult anorectal infection with human papillomavirus in men.

Authors:  G Medley
Journal:  Br J Vener Dis       Date:  1984-06

7.  Genital wart virus infections: nuisance or potentially lethal?

Authors:  A Singer; P G Walker; D J McCance
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-10

8.  Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses.

Authors:  L Dillner; P Heino; J Moreno-Lopez; J Dillner
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

9.  Immunological status to Epstein-Barr virus and cytomegalovirus in patients with genital condylomata.

Authors:  M Zerbini; M Musiani; G Gentilomi; S Costa; M G Poggi; M La Placa
Journal:  Eur J Epidemiol       Date:  1989-09       Impact factor: 8.082

10.  Development of type-specific and cross-reactive serological probes for the minor capsid protein of human papillomavirus type 33.

Authors:  C Volpers; M Sapp; C A Komly; P Richalet-Secordel; R E Streeck
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.